Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (175) Apply Press releases filter
- Basic page (37) Apply Basic page filter
- Pipeline (19) Apply Pipeline filter
- Corporate presentations (17) Apply Corporate presentations filter
- Shareholder meeting (17) Apply Shareholder meeting filter
- Team member (16) Apply Team member filter
- Videos (14) Apply Videos filter
- Financial reports (9) Apply Financial reports filter
- Analyst (7) Apply Analyst filter
- Event (7) Apply Event filter
- Investor contact (6) Apply Investor contact filter
- Webcasts and audio (6) Apply Webcasts and audio filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
Corporate Responsibility
Corporate Responsibility
Recruitment privacy policy
What personal information do we collect from you in the recruitment process?
Oxford BioMedica Directors and Management
Information on the Oxford BioMedica Directors and Senior Management can be found here.
Media contact details
Media enquiries
If you have a general media enquiry, please contact:
LentiVector platform
The LentiVector® platform is the only commercially approved lentiviral-based gene delivery system.
The TRiP System
The TRiP SystemTM maximises viral vector production output and standardises downstream process
Packaging and producer cell lines
Oxford BioMedica has developed packaging and inducible producer cell lines that enable a simplified and scalable manufacturing process whil
Analytical methods
Oxford BioMedica has developed and optimised all the analytics necessary to support product commercialisation.